InNexus Biotechnology, Inc.
IXSBF · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Market Cap | $3 | $10 | $14 | $16 |
| - Cash | $0 | $0 | $3 | $3 |
| + Debt | $3 | $3 | $0 | $0 |
| Enterprise Value | $6 | $13 | $10 | $13 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -93.4% | – |
| Gross Profit | $0 | $0 | -$1 | -$0 |
| % Margin | – | – | -60,403.4% | -1,583.8% |
| EBITDA | -$3 | -$6 | -$5 | -$5 |
| % Margin | – | – | -515,888.8% | -35,991.8% |
| Net Income | -$7 | -$8 | -$6 | -$5 |
| % Margin | – | – | -582,934.9% | -33,861.5% |
| EPS Diluted | -0.07 | -0.11 | -0.11 | -0.13 |
| % Growth | 36.4% | 0% | 15.4% | – |
| Operating Cash Flow | -$2 | -$3 | -$8 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$1 |
| Free Cash Flow | -$2 | -$3 | -$10 | -$3 |